Literature DB >> 29502141

Comment on Saku et al.: Reasons and risk factors for ninety day re-admission following primary total knee arthroplasty in a high-volume centre.

Lucas J Castro Alves1, Mark C Kendall2.   

Abstract

Mesh:

Year:  2018        PMID: 29502141     DOI: 10.1007/s00264-018-3868-0

Source DB:  PubMed          Journal:  Int Orthop        ISSN: 0341-2695            Impact factor:   3.075


× No keyword cloud information.
  6 in total

1.  Pain related readmissions/revisits following same-day surgery: Have they decreased over a decade?

Authors:  Martha O Herbst; Matthew D Price; Roy G Soto
Journal:  J Clin Anesth       Date:  2017-08-06       Impact factor: 9.452

2.  In-hospital costs for total hip replacement performed using the supercapsular percutaneously-assisted total hip replacement surgical technique.

Authors:  James Chow; David A Fitch
Journal:  Int Orthop       Date:  2016-11-12       Impact factor: 3.075

3.  Dose ranging effects of pregabalin on pain in patients undergoing laparoscopic hysterectomy: A randomized, double blinded, placebo controlled, clinical trial.

Authors:  Zahra Asgari; Safoura Rouholamin; Masoomeh Nataj; Mahdi Sepidarkish; Reihaneh Hosseini; Maryam Razavi
Journal:  J Clin Anesth       Date:  2017-01-13       Impact factor: 9.452

4.  Ultrasound-guided transversus abdominis plane block for postoperative analgesia in living liver donors: A prospective, randomized, double-blinded clinical trial.

Authors:  Arzu Kıtlık; Mehmet Ali Erdogan; Ulku Ozgul; Mustafa Said Aydogan; Muharrem Ucar; Huseyin Ilksen Toprak; Cemil Colak; Mahmut Durmus
Journal:  J Clin Anesth       Date:  2017-01-07       Impact factor: 9.452

5.  Health literacy and 30-day postdischarge hospital utilization.

Authors:  Suzanne E Mitchell; Ekaterina Sadikova; Brian W Jack; Michael K Paasche-Orlow
Journal:  J Health Commun       Date:  2012

6.  Reasons and risk factors for ninety day re-admission following primary total knee arthroplasty in a high-volume centre.

Authors:  Sami A Saku; Rami Madanat; Tatu J Mäkinen
Journal:  Int Orthop       Date:  2017-10-25       Impact factor: 3.075

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.